Novartis Investigative Site

Bethesda, Maryland 20892

We've found

3 trials

at this facility

A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Bethesda, MD

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

Status: Enrolling, Phase
Updated: 12/31/1969

from

Bethesda, MD

Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI

Status: Enrolling, Phase II, III
Updated: 12/31/1969

from

Bethesda, MD

Use our guide to learn which trials are right for you!